Keyphrases
Neuromyelitis Optica Spectrum Disorder (NMOSD)
93%
Optic Neuritis
91%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
89%
Multiple Sclerosis
63%
Myasthenia Gravis
28%
Intravenous Immunoglobulin (IVIg)
24%
Myelin Oligodendrocyte Glycoprotein
23%
Aquaporin-4 (AQP4)
21%
Disease Course
20%
Disease Activity
15%
Intravenous Immunoglobulin Therapy
15%
Methylprednisolone
14%
Visual Outcome
14%
Multiple Sclerosis Treatment
13%
Aquaporin-4 IgG
12%
Israel
12%
Multicenter Cohort Study
12%
Lumbar Puncture
12%
Diagnostic Criteria
12%
Optical Coherence Tomography
12%
Obesity
11%
Myelin Oligodendrocyte Glycoprotein IgG
11%
Large Cohort
11%
Type 1 Diabetes Mellitus (T1DM)
11%
Tolerability
11%
Patient Survey
11%
BNT162b2 COVID-19 Vaccine
11%
Oligoclonal Bands
11%
Corticosteroid Treatment
11%
Demyelinating
11%
Interleukin-6
10%
Nervous System Diseases
10%
Annualized Relapse Rate
10%
High-dose Corticosteroids
9%
Relapse Prevention
9%
Transverse Myelitis
9%
Visual Acuity
9%
Retinal Nerve Fiber Layer Thickness (RNFLT)
9%
COVID-19 Vaccine
8%
Myelin Oligodendrocyte Glycoprotein Antibody
8%
Autoimmune Disease
8%
B Cells
8%
Acute Attack
7%
Neurological Diseases
7%
Neurological Conditions
7%
Steroid Treatment
7%
Disease Severity
7%
Central Nervous System Demyelinating Diseases
7%
Healthy Controls
7%
Paraclinical
7%
Neuroscience
Myelin Oligodendrocyte Glycoprotein
100%
Optic Neuritis
80%
Neuromyelitis Optica
71%
Multiple Sclerosis
63%
Intravenous Immunoglobulin
34%
Aquaporin 4
26%
Central Nervous System
17%
Myasthenia gravis
17%
Immunotherapy
15%
Lumbar Puncture
15%
Myelitis
14%
Transverse Myelitis
14%
Nerve Fiber
13%
Methylprednisolone
13%
Prednisone
12%
Oligoclonal Band
11%
Autoimmune Disease
10%
Comorbidity
9%
Brain Disease
8%
Demyelinating Disorder
7%
Autoantibodies
7%
Aquaporin 4 Antibody
7%
Blood Plasma
7%
Mycophenolate Mofetil
6%
Immunoglobulin G
6%
Nervous System Disorder
6%
Diabetes Mellitus
6%
Myelin
6%
Magnetic Resonance Imaging
6%
Interleukin 6
5%
Diabetes Mellitus Type 1
5%
Voltage-Gated Potassium Channel
5%
Parkinson's Disease
5%
B Cell
5%
Neuropathic Pain
5%
Leucine
5%
Spinal Cord Disease
5%
Light Chain
5%
Aseptic Meningitis
5%
Cannabis
5%
MOG Antibody Disease
5%
Polyneuropathy
5%
Non-Motor Symptoms
5%
Amyotrophic Lateral Sclerosis
5%
Experimental Autoimmune Encephalomyelitis
5%
Meningitis
5%
Tocilizumab
5%
Oligodendrocyte
5%
Antigen Antibody Complex
5%
Cognitive Function
5%
Medicine and Dentistry
Optic Neuritis
47%
Multiple Sclerosis
36%
Neuromyelitis Optica
31%
Diseases
26%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
24%
Disease Course
18%
Myelin Oligodendrocyte Glycoprotein
18%
Cerebrospinal Fluid
16%
Lumbar Puncture
16%
Retinal Nerve Fiber Layer
13%
Optical Coherence Tomography
13%
Oligoclonal Band
12%
Systematic Review
11%
Methylprednisolone
9%
Autoimmune Disease
8%
Disease Activity
8%
Retrospective Study
7%
Central Nervous System
7%
Steroid Treatment
7%
Spinal Cord Disease
7%
Plasma Exchange
7%
Comorbidity
7%
Prednisone
6%
Immunoglobulin
6%
Aquaporin 4
6%
Neurologic Disease
6%
Pleocytosis
6%
Intravenous Immunoglobulin Therapy
6%
Cohort Analysis
6%
Myasthenia gravis
5%
Giant-Cell Arteritis
5%
Meningitis
5%
T-Cell Lymphoma
5%
Recurrent Disease
5%
Brain Pseudotumor
5%
Demyelination
5%
Human T-Lymphotropic Virus 1
5%
Insulin Dependent Diabetes Mellitus
5%
Fingolimod
5%
COVID-19 Vaccine
5%
Fever of Unknown Origin
5%
Primary Central Nervous System Lymphoma
5%
Patient with Type 1 Diabetes
5%
Lipomatosis
5%
Varicella Zoster Virus
5%
Aseptic Meningitis
5%
COVID-19
5%
Cancer
5%
Susac Syndrome
5%
Maintenance Therapy
5%
